Sugi Predict

Sugi Predict / Compounds / SCHEMBL286978

SCHEMBL286978

SCHEMBL286978

COc1cc(F)c(F)cc1C#N

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ AR P10275 14/20 0.47
▸ IMPDH2 P12268 1/20 0.46
▸ IMPDH1 P20839 1/20 0.46
▸ HTR2A P28223 1/20 0.44
▸ PGR P06401 1/20 0.44
▸ TRPV4 Q9HBA0 1/20 0.42
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16122074 0.89 KDM4E (0.48) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL3425063 0.89 KDM4E (0.48) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL8437127 0.86 AR (0.47) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL5468223 0.86 AR (0.47) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL11963120 0.85 TRPV4 (0.50) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL2725966 0.84 ALDH1A1 (0.44) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL14720180 0.84 ALDH1A1 (0.44) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL6739415 0.84 ALDH1A1 (0.44) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL21691198 0.84 CYP2D6 (0.48) KDM4EUSP2ALDH1A1ARIMPDH2
SCHEMBL31376036 0.84 CYP2D6 (0.48) KDM4EUSP2ALDH1A1ARIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12208110-B2 Phospholipid compounds and uses thereof GILEAD SCIENCES, INC. (US) 2025-01-28 — — US disclosed
US-11963967-B2 Phospholipid compounds and uses thereof GILEAD SCIENCES, INC. (US) 2024-04-23 — — US disclosed
EP-4228685-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2023-08-23 — — EP disclosed
US-20230248753-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2023-08-10 — — US disclosed
CN-116322759-A Phospholipid compounds and uses thereof 吉利德科学公司 2023-06-23 — — CN disclosed
US-20220143052-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2022-05-12 — — US disclosed
WO-2022081973-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2022-04-21 — — WO disclosed
US-20200039930-A1 PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2020-02-06 — — US disclosed
US-20200039930-A1 PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2020-02-06 — — US disclosed
EP-3601255-A1 PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2020-02-05 — — EP disclosed
US-20030119673-A1 Phenylpyridazinones LINKER KARL-HEINZ (DE) 2003-06-26 — — US disclosed
US-6551963-B1 For controlling unwanted vegetation BAYER AKTIENGESELLSCHAFT (DE) 2003-04-22 — — US disclosed
EP-1070055-A1 SUBSTITUTED PHENYL PYRIDAZINONES Bayer Aktiengesellschaft (DE) 2001-01-24 — — EP disclosed
WO-1999052878-A1 SUBSTITUTED PHENYL PYRIDAZINONES BAYER AKTIENGESELLSCHAFT (DE) 1999-10-21 — — WO disclosed
US-5877121-A HERBICIDE BAYER AKTIENGESELLSCHAFT (DE) 1999-03-02 — — US disclosed
EP-0832072-A1 PHENYLPYRIDAZINONES BAYER AG (DE) 1998-04-01 — — EP disclosed
EP-0804424-A1 SUBSTITUTED PYRIMIDINE(THI)ONES BAYER AG (DE) 1997-11-05 — — EP disclosed
CN-1156991-A Substituted pyrimidine (thi) ones BAYER AG (DE) 1997-08-13 — — CN disclosed
WO-1996039392-A1 PHENYLPYRIDAZINONES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-12 — — WO disclosed
WO-1996007647-A1 SUBSTITUTED PYRIMIDINE(THI)ONES BAYER AKTIENGESELLSCHAFT (DE) 1996-03-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143052-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF PHOSPHO1, SGMS2, SGMS1 KDM4E 3951/4885USP2 4262/4885ALDH1A1 3784/4885
US-20200039930-A1 PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL HTR2C, HTR2A, HTR5A KDM4E 1954/4885USP2 1919/4885ALDH1A1 1031/4885
US-20030119673-A1 Phenylpyridazinones CYP2D6, CYP1A1, CYP1B1 KDM4E 1610/4885USP2 2273/4885ALDH1A1 35/4885
US-12208110-B2 Phospholipid compounds and uses thereof PHOSPHO1, SGMS1, SGMS2 KDM4E 3983/4885USP2 4362/4885ALDH1A1 3479/4885
US-20230248753-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF PHOSPHO1, SGMS2, SGMS1 KDM4E 3951/4885USP2 4262/4885ALDH1A1 3784/4885
US-11963967-B2 Phospholipid compounds and uses thereof PHOSPHO1, SGMS2, SGMS1 KDM4E 3951/4885USP2 4262/4885ALDH1A1 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.